Exhibition 13 February 2024

Minister of Industry and Mineral Resources Lays Foundation Stone for Sudair Pharma’s Insulin Manufacturing Facility

Sudair Pharma was honored to welcome His Excellency the Minister of Industry and Mineral Resources during a special visit to lay the foundation stone for the company’s new insulin manufacturing facility—an important step in strengthening pharmaceutical localization and meeting national healthcare needs.

Sudair Pharma was honored to receive His Excellency the Minister of Industry and Mineral Resources during an official visit to the Sudair Industrial Complex, where he laid the foundation stone for the company’s new insulin manufacturing facility.

This milestone project reflects the Kingdom’s commitment to expanding local pharmaceutical production, strengthening medical security, and supporting the objectives of Saudi Vision 2030 through advanced, high-value manufacturing.

A Strategic National Project

During the ceremony, His Excellency reviewed the facility’s development plans and the technologies that will be integrated into the insulin production lines.

The project marks a major step forward in:

Localizing insulin manufacturing

Strengthening the national pharmaceutical supply chain

Reducing dependency on imported essential medications

Building sustainable, long-term industrial capabilities

The Minister emphasized the importance of expanding local production of vital medicines and highlighted Sudair Pharma’s growing role in supporting national healthcare priorities.

Tour of the Sudair Industrial Complex

The visit also included a detailed tour of the industrial complex, where His Excellency was briefed on:

Sudair Pharma’s current advanced manufacturing capacity

Ongoing research and development programs

Expansion plans aligned with international pharmaceutical standards

National workforce development initiatives

The tour showcased the company’s readiness to host a state-of-the-art insulin facility equipped with high-precision and globally compliant production systems.

Supporting Vision 2030 National Industrial Priorities

The foundation stone ceremony reaffirms Sudair Pharma’s commitment to:

Contributing to the Kingdom’s pharmaceutical industrialization

Enhancing health system resilience

Developing specialized manufacturing capabilities

Empowering national talent across critical scientific and technical fields

Sudair Pharma continues to build its position as a key enabler of national industrial transformation and a strategic partner in strengthening the Kingdom’s drug security.